ACCORD BIOPHARMA Trademark

Trademark Overview


On Monday, March 7, 2022, a trademark application was filed for ACCORD BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the ACCORD BIOPHARMA trademark a serial number of 97298517. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 10, 2024. This trademark is owned by Accord BioPharma, Inc.. The ACCORD BIOPHARMA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

A full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use in the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders for use in connection with humans

Providing healthcare and medical information; Providing information in the fields of Oncology, Immunology, and Critical Care
accord biopharma

General Information


Serial Number97298517
Word MarkACCORD BIOPHARMA
Filing DateMonday, March 7, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2024

Trademark Statements


Goods and ServicesA full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use in the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders for use in connection with humans
Goods and ServicesProviding healthcare and medical information; Providing information in the fields of Oncology, Immunology, and Critical Care
NOT AVAILABLE"BIOPHARMA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code005
First Use Anywhere DateTuesday, November 19, 2019
First Use In Commerce DateTuesday, November 19, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code044
First Use Anywhere DateTuesday, November 19, 2019
First Use In Commerce DateTuesday, November 19, 2019

Trademark Owner History


Party NameAccord BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameAccord BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Thursday, March 10, 2022NEW APPLICATION ENTERED
Friday, March 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 17, 2022ASSIGNED TO EXAMINER
Thursday, January 5, 2023NON-FINAL ACTION WRITTEN
Thursday, January 5, 2023NON-FINAL ACTION E-MAILED
Thursday, January 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 3, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, April 3, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, April 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 24, 2023SUSPENSION LETTER WRITTEN
Wednesday, May 24, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, May 24, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 27, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 8, 2023FINAL REFUSAL WRITTEN
Wednesday, November 8, 2023FINAL REFUSAL E-MAILED
Wednesday, November 8, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 1, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, February 1, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, May 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 3, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, August 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE